Approval · Notice of Compliance 20695 · 2018
LAPELGA: Notice of Compliance 20695
Issued April 5, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20695
- Date
- April 5, 2018
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LAPELGA | 02474565 | Marketed |
Medicinal ingredients
- PEGFILGRASTIM 6 MG per 0.6ML